Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist being researched for its effects on glucose metabolism, insulin sensitivity, and weight regulation. Preclinical and in vitro studies have investigated its potential for metabolic and endocrinological applications. Supplied as a 10mg lyophilized peptide.
For research use only. Not approved for human or animal consumption.